11:06AM ET 7/13/2022 MT NewswiresLeap Therapeutics (LPTX) has an average rating of outperform and price targets ranging from $3 to $6, according to analysts polled by Capital IQ. (MT...
7:47AM ET 7/12/2022 MT NewswiresLeap Therapeutics (LPTX) and BeiGene, Ltd (BGNE) said Tuesday that they have initiated Part C of an ongoing study on Leap's treatment DKN-01 in combination...
5:14AM ET 5/31/2022 MT NewswiresLeap Therapeutics (LPTX) has an average rating of outperform and price targets ranging from $4 to $6, according to analysts polled by Capital IQ. (MT...
7:51AM ET 1/31/2022 MT NewswiresLeap Therapeutics (LPTX) said Monday that it has teamed up with Leica Biosystems to develop a companion diagnostic to detect Dickkopf-related protein 1....